Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023451 · ClinicalTrials.gov registry record
Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients
A clinical trial, sponsored by Akron Children's Hospital.
- Completed
- Registry status
- 21
- Enrollment target
NCT01023451 is a clinical trial that has completed, run by Akron Children's Hospital. The registered enrollment target is 21 participants.
The verdict
NCT01023451 has completed, sponsored by Akron Children's Hospital.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is 1. To determine if Brain natriuretic peptide levels correlates with elevated tricuspid regurgitation flow velocity levels in pediatric patients with sickle cell disease 2. To determine the role of age, gender, steady state hemoglobin and disease type on Brain natriuretic peptide levels and pulmonary hypertension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023451
The ClinicalTrials.gov registry entry for NCT01023451 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akron Children's Hospital, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01023451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023451 about?
NCT01023451 is a clinical study titled "Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients". The purpose of this study is 1. To determine if Brain natriuretic peptide levels correlates with elevated tricuspid regurgitation flow velocity levels in pediatric patients with sickle cell disease 2. To determine the role of age, gender, steady state hemoglobin and disease type on Brain natriureti...
What is the current status of trial NCT01023451?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2009-12. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01023451?
This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.